-
- Patient Now Approved Initial Page
-
- Patient Now Approved Homepage
-
- Patient Now Approved Homepage on Mobile
-
- Patient Now Approved Level 2 Page
-
- HCP Now Approved Homepage
Repatha Now Approved
Brand: Repatha (evolocumab), Injection
Parent Company: Amgen
Drug Type: Prescription
Drug Category: Cardiovascular
Campaign: now-approved
Targeting: HCPs, Patients
Patient Website: https://www.repatha.com/
HCP Website: https://www.repathahcp.com/